Last reviewed · How we verify
Keytruda — side effects
Pembrolizumab blocks PD-1 receptor, releasing immune inhibition and enhancing anti-tumor T-cell response.
Common side effects
- Nausea
- Fatigue
- Anaemia
- Diarrhoea
- Constipation
- Decreased appetite
- Hypothyroidism
- Vomiting
- Pruritus
- Arthralgia
- Hypertension
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Asthenia
- Rash
- Cough
- Headache
- Weight decreased
- Pyrexia
- Abdominal pain
See also
- Full profile: Keytruda
- Dosage & administration: /dosage
- Mechanism of action: /mechanism
- Cost & pricing: /cost
- Drug interactions: /interactions
- Clinical trials: /clinical-trials
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing